Joel Walbert on Nostr: African Vaccine Manufacturing Accelerator (AVMA) What is AVMA? The African Vaccine ...
African Vaccine Manufacturing Accelerator (AVMA)
What is AVMA?
The African Vaccine Manufacturing Accelerator (AVMA) is a financing mechanism established to make up to US$ 1.2 billion available over ten years commencing with AVMA’s launch in June 2024 to accelerate the expansion of commercially viable vaccine manufacturing in Africa.
AVMA offers a ‘pull financing mechanism’ by providing downstream incentives to manufacturers to help offset initial costs of development and production.
The instrument was approved by the Gavi Board in December 2023 and launched in June 2024, following a design process conducted over nearly two years of close collaboration between Gavi, the African Union and the Africa Centres for Disease Control and Prevention (Africa CDC), with extensive consultations with partners, donors, industry, civil society and other stakeholders.
https://www.gavi.org/programmes-impact/types-support/regional-manufacturing-strategy/avma
What is AVMA?
The African Vaccine Manufacturing Accelerator (AVMA) is a financing mechanism established to make up to US$ 1.2 billion available over ten years commencing with AVMA’s launch in June 2024 to accelerate the expansion of commercially viable vaccine manufacturing in Africa.
AVMA offers a ‘pull financing mechanism’ by providing downstream incentives to manufacturers to help offset initial costs of development and production.
The instrument was approved by the Gavi Board in December 2023 and launched in June 2024, following a design process conducted over nearly two years of close collaboration between Gavi, the African Union and the Africa Centres for Disease Control and Prevention (Africa CDC), with extensive consultations with partners, donors, industry, civil society and other stakeholders.
https://www.gavi.org/programmes-impact/types-support/regional-manufacturing-strategy/avma
quoting nevent1q…qjuydated August 7. How fucking convenient that a week later the WHO declares a mpox emergency because of Africa.
'A new effort to foster vaccine production in Africa will incentivize the use of technologies that support efficient, low-cost manufacturing, according to Gavi, the Vaccine Alliance, which brings together governments, the WHO, UNICEF, the Gates Foundation, and industry. Gavi recently launched the African Vaccine Manufacturing Accelerator (AVMA), describing it as a $1.2 billion financing mechanism designed to foster vaccine production and sovereignty in the continent.'
https://www.genengnews.com/topics/bioprocessing/african-vaccines-sector-plans-to-incentivize-use-of-innovative-tech/
#breakthestate #anarchy #mmh #donotcomply